NMG
FLGT icon

New Millennium Group’s Fulgent Genetics FLGT Stock Holding History

New Millennium Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$26 Buy
+1
New +$26 ﹤0.01% 385

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New Millennium Group's FLGT Position: Q4 2025 in Review

New Millennium Group opened a new position in Fulgent Genetics (FLGT) in Q4 2025: 1 share worth $26. The stake represents ﹤0.01% of the portfolio and ranks #385 among its holdings.

179 funds tracked by Wall St. Rank hold FLGT as of Q4 2025.

  • New Millennium Group held 1 share of Fulgent Genetics worth $26 as of Q4 2025.
  • Fulgent Genetics was a new New Millennium Group position in Q4 2025.
  • Fulgent Genetics made up ﹤0.01% of New Millennium Group's portfolio in Q4 2025, its #385 holding.
  • 179 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.